Smartphones Spot Ocular Malignancies
Could a smartphone-based AI system bring ocular oncology screening directly into the patient’s home?
-
1
A smartphone-based AI platform named CaptureTumor (CaT) aims to improve early detection of ocular surface malignancies.
-
2
The system utilizes smartphone photography and automated image analysis to classify lesions as benign or malignant.
-
3
In a clinical trial, the app achieved an AUC of 0.977, with sensitivity of 89.3% and specificity of 95.9% in real-world screening.
-
4
The platform identified 20 confirmed malignancies, with 19 cases being previously undiagnosed, suggesting earlier detection.
-
5
The study demonstrates the potential of consumer technologies in enhancing public health and access to specialist eye care.
